Search results for abx376500

Imdevimab, Abbexa, abx376500

This product is for research use only (RUO) by laboratories. It is not suitable for use in humans or as a medicine. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2/COVID-19) Spike Protein RBD Neutralizing Antibody (Imdevimab) is a research grade recombinant Human Monoclonal Antibody biosimilar against SARS-CoV-2/COVID-19 Spike Protein RBD. The SARS-CoV-2 Spike Protein (S protein) is a viral protein that allows the entry of SARS-CoV-2 into human cells. The protein forms trimers on the viral capsid and binds to human Angiotensin Converting Enzyme 2 (ACE2) located on the cell surface. The protein has a cleavage site between the S1 and S2 subunits that is targeted by the human enzyme Furin, and it may also cause the development of a syncytium (cell fusion). Antibodies to S protein can prevent viral entry as well as target the virus for further immune action.